Back
Encore Wire 10K Form
Buy
54
WIRE
Encore Wire
Last Price:
283.30
Seasonality Move:
5.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | WIRE/Encore Wire Quarterly |
| 2023-07-27 | 10Q | WIRE/Encore Wire Quarterly |
| 2023-04-27 | 10Q | WIRE/Encore Wire Quarterly |
| 2022-10-27 | 10Q | WIRE/Encore Wire Quarterly |
| 2022-07-27 | 10Q | WIRE/Encore Wire Quarterly |
| 2022-04-28 | 10Q | WIRE/Encore Wire Quarterly |
Receive WIRE News And Ratings
See the #1 stock for the next 7 days that we like better than WIRE
WIRE Financial Statistics
Sales & Book Value
| Annual Sales: | $2.57B |
|---|---|
| Cash Flow: | $51.89M |
| Price / Cash Flow: | 19.2 |
| Annual Sales: | $114.88 |
| Price / Book: | 2.48 |
Profitability
| EPS (TTM): | 18.85000 |
|---|---|
| Net Income (TTM): | $316.19M |
| Gross Margin: | $655.88M |
| Return on Equity: | 17.7% |
| Return on Assets: | 15.81% |
Encore Wire Earnings Forecast
Key Encore Wire Financial Ratios
- The Gross Profit Margin over the past 33 years for WIRE is 25.54%.
- The Selling, General & Administrative Expenses for WIRE have been equal to 7.96% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of WIRE is 14.50% of Total Revenues.
- Per Share Earnings over the last 33 years have been positive in 21 years.
Encore Wire Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Electrical Equipment |
| Sector: | Industrials |
| Current Symbol: | WIRE |
| CUSIP: | 292562 |
| Website: | encorewire.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.49 |
| Quick Ratio: | 6.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.18 |
|---|---|
| Forward P/E Ratio: | 13.95 |
WIRE Technical Analysis vs Fundamental Analysis
Buy
54
Encore Wire (WIRE)
is a Buy
Is Encore Wire a Buy or a Sell?
-
Encore Wire stock is rated a Buy
The current Encore Wire [WIRE] share price is $284.89. The Score for WIRE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.